Clinical Research Directory
Browse clinical research sites, groups, and studies.
Injection Sclerotherapy With Bleomycin VS Doxycycline in Patients With Lymphatic Malformations
Sponsor: Basharat Hussain
Summary
This is a randomized clinical trial comparing the safety and effectiveness of injection sclerotherapy using bleomycin versus doxycycline in children under 12 years with lymphatic malformations. The study will assess reduction in lesion size, clinical improvement, and treatment-related complications over six months.
Official title: Injection Sclerotherapy With Bleomycin VS Doxycycline in Patients With Lymphatic Malformations:A Randomized Controlled Trial
Key Details
Gender
All
Age Range
0 Years - 12 Years
Study Type
INTERVENTIONAL
Enrollment
92
Start Date
2026-01-26
Completion Date
2026-09-26
Last Updated
2026-01-06
Healthy Volunteers
No
Conditions
Interventions
Bleomycin
Injection sclerotherapy using bleomycin administered according to standard hospital protocol. The number of sessions and dosage are determined based on lesion size and patient response. Safety and adverse events are monitored by the principal investigator and treating physicians.
doxycycline (tetracycline)
Injection sclerotherapy using doxycycline administered according to hospital protocol. The number of sessions and dosage are determined based on lesion size and patient response. Safety and adverse events are monitored by the principal investigator and treating physicians.